About Fuzionaire Theranostics
Fuzionaire Theranostics is a company based in The Woodlands (United States) founded in 2018. It operates as a B2B. Fuzionaire Theranostics offers products and services including HetSiFA Platform and GRPR Theranostic Pair. Fuzionaire Theranostics operates in a competitive market with competitors including Advanced Accelerator Applications, SOFIE, Mariana Oncology, AdvanCell and Ariceum Therapeutics, among others.
- Headquarter The Woodlands, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fuzionaire Theranostics
Fuzionaire Theranostics offers a comprehensive portfolio of products and services, including HetSiFA Platform and GRPR Theranostic Pair.
Enables creation of personalized cancer diagnostics and therapies.
Targets prostate cancer receptors for diagnostic and treatment purposes.
Funding Insights of Fuzionaire Theranostics
Detailed funding history for Fuzionaire Theranostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fuzionaire Theranostics
Investment portfolio details for Fuzionaire Theranostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fuzionaire Theranostics
Detailed financials for Fuzionaire Theranostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fuzionaire Theranostics Comparisons
Peer comparison for Fuzionaire Theranostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fuzionaire Theranostics
Fuzionaire Theranostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advanced Accelerator Applications, SOFIE, Mariana Oncology, AdvanCell and Ariceum Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of molecular imaging systems and radio-pharmaceuticals
|
|
| Locked | Locked | Locked |
Targeted radiopharmaceuticals for solid tumors are developed and pioneered.
|
|
| Locked | Locked | Locked |
Radiopharmaceutical company developing targeted alpha therapies for cancer treatment
|
|
| Locked | Locked | Locked |
Developer of drugs for systemic targeted radiation therapy to treat cancer
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging agents and targeted therapeutics
|
Detailed competitors of Fuzionaire Theranostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fuzionaire Theranostics
Complete news archive for Fuzionaire Theranostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fuzionaire Theranostics
Fuzionaire Theranostics was founded in 2018.
Fuzionaire Theranostics is headquartered in The Woodlands, United States. It is registered at The Woodlands, Texas, United States.
Fuzionaire Theranostics focuses on creating radiopharmaceuticals for theranostics, combining PET diagnostics and radioligand therapies. Using the HetSiFA platform derived from breakthroughs at Caltech, they produce chemically identical diagnostic and therapeutic agents. This enables personalized cancer care by targeting specific receptors, such as in prostate cancer. Based in the USA, they collaborate with institutions to scale treatments and address oncology needs, improving accessibility for patients.
Fuzionaire Theranostics's top competitors include Advanced Accelerator Applications, SOFIE and AdvanCell.
Fuzionaire Theranostics offers HetSiFA Platform and GRPR Theranostic Pair.